Ascribe & Microsoft tackle the issue of venous thromboembolism (VTE)
23rd November 2011 – Ascribe, the leading provider of integrated clinical solutions, announces today that it has undertaken a joint initiative with Microsoft® to tackle the issue of venous thromboembolism (VTE). According to the NHS, VTE causes 25,000 avoidable deaths a year and costs the taxpayer £640m. (http://www.guardian.co.uk/society/2007/apr/20/health)
“The All-Party Parliamentary Thrombosis Group (APPTG) has recommended that a CQUIN-compliant electronic VTE risk assessment template is used by clinicians. In fact, Electronic VTE assessment solutions are cited to raise compliance on VTE assessment from 30% to over 90% in 1 year”.
(Source: Whittington NHS Trust)
Whilst the government has made VTE a clinical priority, recent research by E-Health Insider (EHI) indicated that there are a still considerable number of trusts who are not complying with current CQUIN standards, and more than 80% of trusts surveyed still undertake the burden of collecting VTE assessments manually. Not only is this a patient safety issue, it also impacts upon the clinical productivity and trust finances.
Ascribe Consulting, in partnership with Microsoft, has developed a clinically based VTE solution, which enables VTE compliance and management to meet and exceed current CQUIN targets.
An important component of the solution is its real-time reporting, this enables more responsive patient care and greater clarity of VTE compliance at multiple levels: the hospital, the ward and patient level. Lack of compliance will quickly alert clinicians and managers, using mobile technology. Patient level data can be quickly reviewed for root cause analysis, and our business intelligence dashboard provides real time reporting for management and audit purposes.
To promote this VTE risk-assessment & root cause analysis solution, Ascribe & Microsoft are hosting a series of webinars to VTE leads & Haematology Clinicians. The first, entitled, “VTE – Beyond CQUIN targets” will be held on the 14th December 2011. To register for this webinar or to request more information, please contact Urszula Bennett at urszula.bennett@ascribe.com or Simon Josephs at simon.josephs@microsoft.com.
For further information, please contact:
Simon Mehlman, Marketing Manager, simon.mehlman@ascribe.com
Claire Williams, Marketing Coordinator, claire.williams@ascribe.com
Ascribe Ltd Tel: +44 (0) 870 053 4545
Alex Gray, Senior Marketing Manager Europe, alex.gray@microsoft.com
Microsoft Health Solutions Group
Tel: +44 (0) 1189 094 819
About Microsoft
Founded in 1975, Microsoft (Nasdaq “MSFT”) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.
Microsoft is committed to improving health around the world through software innovation. Over the past 13 years, Microsoft has steadily increased its investments in health with a focus on addressing the challenges of health providers, health and social services organizations, payers, consumers and life sciences companies worldwide. Microsoft closely collaborates with a broad ecosystem of partners and delivers its own powerful health solutions, such as Amalga, HealthVault, and a portfolio of identity and access management technologies acquired from Sentillion Inc. in 2010. Together, Microsoft and its industry partners are working to deliver health solutions for the way people aspire to work and live.
About Ascribe Consulting
Informing healthcare decisions using appropriate information, and improving health outcomes through the use of informed clinical intelligence have always been at the heart of Ascribe’s vision and mission. Ascribe Consulting has established itself as a trusted partner in over 70 NHS Trusts and provides a wide range of health and social care organisations with access to performance KPIs, operational or clinical dashboards or direct access to data using analytical tools.
Ascribe Consulting has developed a broad range of Healthcare solutions built upon Microsoft’s SharePoint® technology and also creates NHS Business Intelligence Portals using the Microsoft® Business Intelligence (BI) software stack, best practice data warehouse design methodologies and most importantly an extensive health sector experience.
About Ascribe
Over 75% of NHS Trusts use Ascribe systems and our commitment to improving healthcare IT has made us a strategic partner for a growing number of Trusts.
Ascribe’s clinical systems and consultancy services are robust and scalable, from departmental systems through to strategic enterprise-scale solutions. The company is a Microsoft Gold Partner and has been awarded Finalists in Microsoft’s Healthcare Partner of the Year awards. From Electronic Prescribing through to Paperless Clinical Management and even Pharmacy robotic interfaces, Ascribe’s breadth of integrated systems has been proven to help Trusts improve patient safety, improve their operational efficiency and reduce operational costs.
Ascribe employs 300 personnel through its operating companies in the UK, Kenya, Australia and New Zealand. For more information, please visit http://www.ascribe.com
